TABLE 4

Concentration of oxycodone HCl metabolites in human liver microsomal samples incubated with 200 µM oxycodone HCl at pH 10

Values are expressed as means ± S.D.

Human Liver MicrosomeTimeOxycodoneOxycodone N-OxideNoroxycodoneOxymorphoneNoroxymorphone
minnmol/ml(nmol/ml)/mg protein
HK37a0210.50 ± 1.700.32 ± 0.0010.42 ± 0.090.04 ± 0.010.013 ± 0.018
10196.70 ± 10.610.63 ± 0.015.08 ± 0.180.97 ± 0.02ND
20205.35 ± 0.640.70 ± 0.055.89 ± 0.111.12 ± 0.060.09 ± 0.08
HH18b0166.03 ± 4.080.27 ± 0.050.45 ± 0.090.02 ± 0.004ND
10170.33 ± 9.080.37 ± 0.081.07 ± 0.120.07 ± 0.004ND
20163.73 ± 6.250.32 ± 0.0010.42 ± 0.090.14 ± 0.02ND
  • ND, not detected.

  • a CYP3A4 activity was 2.5 (nmol of product/min)/mg protein in the testosterone 6β-hydroxylase assay. FMO activity was 3.6 (nmol of product/min)/mg protein in the methyl p-tolyl sulfide oxidase assay.

  • b CYP3A4 activity was 12.0 (nmol of product/min)/mg protein in the testosterone 6β-hydroxylase assay. FMO activity was 2.8 (nmol of product/min)/mg protein in the methyl p-tolyl sulfide oxidase assay.